Irenic Capital Management

Overview

Irenic Capital Management is a private investment firm specializing in value-oriented strategies across various asset classes and industries. The firm focuses on distressed and special situations, private equity, and other investment opportunities, aiming to create value through active management and strategic interventions. Established in 2021, Irenic Capital Management has been involved in several high-profile investments and shareholder engagements. The firm has a history of collaborating with publicly traded companies to align operating activities, capital deployment, and management incentives, thereby enhancing value for shareholders. Notable engagements include agreements with companies like Barnes Group Inc. and Theravance Biopharma, Inc., where Irenic secured board representation and influenced strategic decisions. The firm's investment approach is characterized by a hands-on strategy, focusing on underperforming or undervalued companies with potential for turnaround or growth. Irenic Capital Management's team, led by co-founders Adam Katz and Andy Dodge, brings extensive experience in investment management and corporate governance, enabling them to effectively implement value-creation strategies in complex situations.

Investment Focus

• Active management involvement
• Board representation
• Strategic restructuring
• Capital deployment alignment
• Shareholder value enhancement

Portfolio Companies